Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Endocrinol (Oxf) ; 85(5): 725-732, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27497063

RESUMO

Bone turnover markers (BTMs) provide important insights into the dynamics of bone remodelling and are subjected to preanalytical and ethnic variations in addition to influence of genetic and environmental factors. AIM/OBJECTIVES: To derive ethnicity specific reference range for BTMs and to study their correlation with Bone Mineral Density (BMD) in a cohort of healthy postmenopausal women and their premenopausal daughters and to look at the impact of maternal bone mineral status on daughters bone health. MATERIAL AND METHODS: This community based cross sectional study included 300 subjects (150 mother-daughter pairs). Demographic details were collected. Fasting blood and a second void morning urine samples were obtained for measurement of BTMs (sCTX, sPTNP1, sOC and urine DPD respectively) and bone mineral parameters. BMD was measured by DXA scan. RESULTS: Osteoporosis was seen in 44·7% of the postmenopausal women. Ethnicity specific reference ranges of BTMs were derived for the study population. Significant inverse correlation was found between all BTMs (except urine DPD) and BMD(P < 0·05). Daughters of mothers with osteoporosis at spine and femoral neck had lower BMD, compared to daughters of mothers without osteoporosis(P = 0·03 & 0·05). CONCLUSION: Apart from deriving the ethnicity specific reference range for BTMs and finding a significant inverse correlation between BTM and BMD, this study found significantly lower BMD in daughters of mothers with osteoporosis at spine and femoral neck implicating the probable interplay of genetic, epigenetic and similar environmental factors.


Assuntos
Densidade Óssea , Remodelação Óssea , Mães , Núcleo Familiar , Osteoporose/etnologia , Osteoporose/etiologia , Absorciometria de Fóton , Adulto , Biomarcadores/sangue , Biomarcadores/urina , Estudos Transversais , Feminino , Colo do Fêmur/patologia , Humanos , Índia , Pessoa de Meia-Idade , Osteoporose/diagnóstico , Osteoporose/genética , Pós-Menopausa , Pré-Menopausa , Coluna Vertebral/patologia
2.
Nephrology (Carlton) ; 10(6): 588-93, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16354242

RESUMO

BACKGROUND: To date, there is no specific antidote to acetaminophen poisoning. Propylthiouracil (PTU) has been shown to be protective against acetaminophen (APAP)-induced liver damage in rats; however, the nephroprotective effect of propylthiouracil has not been studied yet. METHODS: In order to verify this, rats were given different doses of PTU (100, 200 or 400 mg/kg per body weight, orally) 1 h before a nephrotoxic dose of APAP (1,000 mg/kg per body weight, intraperitoneally (i.p.)). RESULTS: Propylthiouracil pretreatment significantly reduced APAP-induced nephrotoxicity in a dose-dependant manner, as evidenced by reduction in plasma creatinine and by amelioration of renal pathology (interstitial congestion, tubular cell degeneration and necrosis). CONCLUSION: The mechanism of protection by PTU is probably not due to the sparing effect of non-protein thiol (approximately 95% of which is reduced glutathione), as similar depletion of renal glutathione was observed regardless of PTU pretreatment; other mechanisms are suggested.


Assuntos
Acetaminofen/toxicidade , Nefropatias/induzido quimicamente , Propiltiouracila/uso terapêutico , Animais , Creatinina/sangue , Relação Dose-Resposta a Droga , Rim/metabolismo , Rim/patologia , Nefropatias/tratamento farmacológico , Nefropatias/metabolismo , Nefropatias/patologia , Peróxidos Lipídicos/metabolismo , Masculino , Ratos , Ratos Wistar , Compostos de Sulfidrila/metabolismo , Ureia/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA